Choosing the Product Format for Aggrastat (tirofiban hydrochloride) Injection |
Creatinine Clearance Calculation Video for Aggrastat (tirofiban hydrochloride) Injection |
Educational Video on How to Use the 100 mL Vial for Delivery of Aggrastat (tirofiban hydrochloride) Injection |
Educational Video on How to Use the 15 mL Bolus Vial in Combination with the 100 mL Vial of Aggrastat (tirofiban hydrochloride) Injection |
Educational Video on How to Use the 250 mL Bag for Delivery of Aggrastat (tirofiban hydrochloride) Injection |
Indication:
Aggrastat® is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
Contraindications:
Warnings and Precautions:
Adverse Reactions:
For additional information, refer to the full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch
or call 1-800-FDA-1088.